MedPath
NMPA Approval

Olmesartan Medoxomil Tablets

国药准字H20243539

April 17, 2024

Drug Information

奥美沙坦酯片

片剂

20mg

化学药品

April 17, 2024

Company Information

Applicant Company

成都高新区西部园区百草路18号

Manufacturing Company

成都高新区西部园区百草路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯片 - NMPA 批准文号 | MedPath